Kyowa Kirin is continuing to monitor the COVID-19 outbreak. Learn More
Important Safety Information
This website is intended forhealthcare providers in the US
* Indicates a required field
To report suspected adverse reactions with POTELIGEO® (mogamulizumab-kpkc) Injection, contact Kyowa Kirin at 1-844-768-3544, or the FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.
This form is only for use by citizens of the United States. We are collecting this personal information in order to respond to the inquiry you are sending via this contact form. Kyowa Kirin understands the importance of protecting your information and will use your information for the sole purpose of responding to your inquiry. Please note that our response to your inquiry will be sent through Internet email, which is not secure and may include the personal information you provided us in your inquiry.
Kyowa Kirin, Inc. respects your interest in keeping your personal and professional information private. We will not sell or rent your information to any third parties or outside mailing lists.
We will send you the latest updates about POTELIGEO® (mogamulizumab-kpkc), as well as helpful information for you, your staff, and your patients.